IP Library Assignment 072700/0001
Patent Assignment
Reel/Frame 072700/0001

Security Interest

Recorded: 2025-10-28 Pages: 10
Assignors
STRATATECH CORPORATION
Executed: 2025-08-01
SUCAMPO PHARMA AMERICAS LLC
Executed: 2025-08-01
VTESSE LLC
Executed: 2025-08-01
Assignee
GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
200 WEST STREET, ATTENTION OF BANK DEBT PORTFOLIO GROUP, NEW YORK, NEW YORK, 10282
Covered Properties (40)
Method for Manufacturing Prostaglandin Analogue
Patent: 7,321,057 →
Application: 11/193,373 →
Publication: US 2006/0036108
Method for Treating Gastrointestinal Disorder
Patent: 8,748,481 →
Application: 11/216,012 →
Publication: US 2006/0063830
Human skin equivalents expressing exogenous polypeptides
Patent: 9,163,076 →
Application: 11/365,357 →
Publication: US 2006/0257383
Skin substitutes with improved purity
Patent: 9,295,543 →
Application: 11/375,950 →
Publication: US 2006/0258001
Soft-Gelatin Capsule Formulation
Patent: 8,026,393 →
Application: 11/656,476 →
Publication: US 2007/0172523
Pharmaceutical Composition Comprising a Bi-Cyclic Compound and Method for Stabilizing the Bi-Cyclic Compound
Patent: 7,985,770 →
Application: 11/656,513 →
Publication: US 2007/0172522
Method for Preparing 15-Keto-Prostaglandin E Derivative
Patent: 7,355,064 →
Application: 11/703,098 →
Publication: US 2007/0185206
Method for Preparing Prostaglandin Derivative
Patent: 7,812,182 →
Application: 11/703,138 →
Publication: US 2007/0244333
Method for Promoting Gastrointestinal Bicarbonate Secretion
Patent: 7,868,045 →
Application: 11/850,271 →
Publication: US 2008/0070979
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 8,580,314 →
Application: 12/612,284 →
Publication: US 2010/0119615
Method for Preparing Prostaglandin Derivative
Patent: 8,236,969 →
Application: 12/762,890 →
Publication: US 2010/0204491
Method for Preparing Prostaglandin Derivative
Patent: 8,304,562 →
Application: 12/762,906 →
Publication: US 2010/0274032
Method for Preparing Prostaglandin Derivative
Patent: 8,389,748 →
Application: 12/762,917 →
Publication: US 2010/0204489
Facilitating Noise Estimation in Wireless Communication
Patent: 8,929,324 →
Application: 12/834,554 →
Publication: US 2011/0188466
Method for Promoting Upper Gastrointestinal Bicarbonate Secretion
Patent: 8,530,519 →
Application: 12/952,626 →
Publication: US 2011/0065784
Pharmaceutical Composition Comprising a Bi-Cyclic Compound and Method for Stabilizing the Bi-Cyclic Compound
Patent: 8,669,284 →
Application: 13/161,060 →
Publication: US 2011/0244036
Soft-Gelatin Capsule Formulation
Patent: 8,338,639 →
Application: 13/210,556 →
Publication: US 2011/0300211
Method for Preparing a Fatty Acid Derivative
Patent: 9,242,950 →
Application: 13/538,189 →
Publication: US 2013/0005995
Soft-Gelatin Capsule Formulation
Patent: 8,779,187 →
Application: 13/679,005 →
Publication: US 2013/0078303
Use of Delta Tocopherol for the Treatment of Lysosomal Storage Disorders
Patent: 9,044,451 →
Application: 13/810,774 →
Publication: US 2013/0123214
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 8,685,463 →
Application: 14/054,445 →
Publication: US 2014/0067064
Cryopreservation of Viable Human Skin Substitutes
Application: 14/208,439 →
Publication: US 2014/0271583
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 8,992,997 →
Application: 14/220,320 →
Publication: US 2014/0288165
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 9,526,811 →
Application: 14/669,095 →
Publication: US 2015/0196686
Use of Delta Tocopherol for the Treatment of Lysosomal Storage Disorders
Application: 15/239,753 →
Publication: US 2017/0027903
Cold Storage of Organotypically Cultured Skin Equivalents for Clinical Applications
Application: 15/375,755 →
Publication: US 2017/0339943
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 9,867,904 →
Application: 15/377,323 →
Publication: US 2017/0087276
Pharmaceutical Combination of Opioid and Prostaglandin Compound
Application: 15/805,759 →
Publication: US 2018/0311233
Cryopreservation of Viable Human Skin Substitutes
Application: 16/122,598 →
Publication: US 2019/0000071
Use of Human Skin Substitutes Expressing Exogenous Il-12 to Treat a Wound Bed
Application: 16/150,048 →
Publication: US 2019/0030130
Multilayer Beads for Pharmaceutical Use
Application: 16/338,948 →
Publication: US 2020/0390708
Tissue Container Systems
Application: 16/481,405 →
Publication: US 2020/0128815
Cryopreservation of Viable Human Skin Substitutes
Application: 17/694,245 →
Publication: US 2022/0192181
Methods for Treating Acute Wounds and Improving Outcomes
Application: 17/763,552 →
Publication: US 2022/0347353
Tissue Container Systems
Application: 17/827,270 →
Publication: US 2022/0287298
Engineered Skin Construct Overlay of Autograft
Application: 18/014,951 →
Publication: US 2023/0330153
Methods for Priming Allogeneic Cultured Keratinocyte Compositions for Topical Use
Application: 18/565,003 →
Publication: US 2024/0245729
Tissue Container Systems
Application: 18/565,005 →
Publication: US 2024/0245050
Allogeneic Cultured Keratinocyte Products
Application: 18/565,007 →
Publication: US 2024/0358766
Viable Bioengineered Allogeneic Cellularized Skin Constructs That Secrete Soluble Factors Associated with Regenerative Wound Healing
Application: 18/568,672 →
Publication: US 2024/0207487
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Patents Sep 16, 2016
From: STRATATECH CORPORATION
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 040059/0222 →
Security Interest Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Conversion Jan 22, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051666/0768 →
Partial Assignment Jan 23, 2020
From: R-TECH UENO, LTD.
To: SUCAMPO AG
Reel/Frame 051681/0987 →
Assignment of Assignor's Interest Jan 23, 2020
From: UENO, RYUJI
To: R-TECH UENO, LTD.
Reel/Frame 051599/0266 →
Assignment of Assignor's Interest Jan 23, 2020
From: HASHITERA, YUKIKO; HIRATA, RYU; HARADA, YASUHIRO
To: R-TECH UENO, LTD.
Reel/Frame 051599/0086 →
Conversion Jan 27, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051708/0596 →
Release of Security Interest Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913 Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 040059, Frame 0222 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0083 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Security Interest Aug 1, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 071913/0691 →
Release of Security Interest Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →